Effect of omalizumab on asthma control, exacerbation rate and quality of life in Italian patients with severe allergic asthma: results from the longitudinal phase of the proxima study

被引：0

作者：

Caruso, C. ^{[1
]}

Rottoli, P. ^{[2
]}

Bucca, C. ^{[3
]}

Zappa, M. C. ^{[4
]}

Berlendis, M. A. ^{[5
]}

Michetti, G. ^{[6
]}

Macciocchi, B. ^{[7
]}

Bartezaghi, M. ^{[8
]}

Rigoni, L. ^{[8
]}

Canonica, G. W. ^{[9
]}

机构：

[1] Fdn Policlin Gemelli Presidio Columbus, Allergy Unit, Rome, Italy

[2] Univ Siena, Resp Dis & Lung Transplant Unit, AOUS, Dept Med Surg & Neuro Sci, Siena, Italy

[3] Univ Turin, Dept Med Sci, Pneumol Unit, Turin, Italy

[4] Sandro Pertini Hosp, Div Lung Dis, Rome, Italy

[5] Spedali Civili Brescia, Cardiothorac Dept, Pneumol Unit, Brescia, Italy

[6] Pneumol AO Papa Giovanni XXIII, Bergamo, Italy

[7] Hosp St Scholast, Pneumol Unit, Cassino, Italy

[8] Largo Univ Boccioni 1, Novartis Farma SpA, Origgio, Italy

[9] Humanitas Univ Rozzano, Dept Biomed Sci, Humanitas Clin & Res Ctr, Personalized Med Clin Asthma & Allergy, Milan, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

0663

引用

页码：415 / 416

页数：2